European Journal of Cancer
Volume 41, Issue 11 , Pages 1501-1502 , July 2005

Confirmation of response in cancer clinical trials: A meaningless exercise?

  • P. Therasse

      Affiliations

    • Corresponding Author InformationTel.: +32 2 774 16 14; fax: +32 2 772 61 97.

Received 15 April 2005 ,Accepted 15 April 2005.

References 

  1. Hayward JL, Carbone PP, Heuson JC, et al. Assessment of response to therapy in advanced breast cancer: a project of the programme on clinical oncology of the international union against cancer, Geneva, Switzerland. Cancer. 1977;39(3):1289–1294
  2. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205–216
  3. Pignatti F, Aronsson B, Vamvakas S, et al. Clinical trials for registration in the European Union: the EMEA 5-year experience in oncology. Crit Rev Oncol Hematol. 2002;42(2):123–135
  4. Dagher R, Johnson J, Williams G, et al. Accelerated approval of oncology products: a decade of experience. J Natl Cancer Inst. 2004;96(20):1500–1509

PII: S0959-8049(05)00348-5

doi: 10.1016/j.ejca.2005.04.021

European Journal of Cancer
Volume 41, Issue 11 , Pages 1501-1502 , July 2005

Article Tools